Venkataraman V, Duda T, Galoian KA, Sharma R. Molecular and pharmacological identity of alpha 2D adrenergic receptor in bovine retina and its photoreceptors. Mol. and Cell. Biochem. 159:129-138,1996.
Aprikian VS, Galoian KA, Galoyan AA. Influence of hypothalamic polypeptides on cell mediated immune response. Neirokhimiya 15:182-195, 1998.
Galoian KA. Measurement of changes in calcium levels in isolated cardiac nerve terminals using confocal microscopy. Neirokhimiya. 15: 373-379., 1998.
Galoian KA, Milne T, Brock H, Shilatifard A, Slany R, Hess J. Deregulation of c-MYC by leukemogenic MLL Fusion proteins. BLOOD, v.96, n 11 Nov.16. p.457( a ), 2000.
Martin M, Milne T, Bloyer S, Galoian KA , Shen W, Gibbs D, Brock H, Slany R, Hess J. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 4:197-207, 2003.
Galoian KA, Garamszegi N, Garamszegi S, Scully S. Molecular Mechanism of Tenascin C Action on Matrix Metalloproteinase -1 Invasive Potential. Experimental Biology and Medicine. April,v.232, issue 4, 515-522, 2007.
Galoyan AA, Danielian KE, Galoian KA, Kramer A, Davtian TK, Bezirganian K, Kriegerstein J. Effect of hypothalamic neurosecretory cytokine proline rich polypeptides (PRP) on the neuronal and hematopoietic cell apoptosis. Neurochemical Research. June, 32 (11), 1898-1905, 2007.
Galoian KA, Scully SP, Galoyan AA. Myc-oncogene inactivating effect of Proline Rich Polypeptides (PRP-1) in the Human Chondrosarcoma JJ012 cells. Neurochemical Research v 34, issue 2, 379-385, 2009.
Galoian K, Scully S, McNamara G, Flynn P, Galoyan A. Antitumorigenic effect of brain Proline Rich Polypeptide-1 in Human Chondrosarcoma. Neurochemical research , vol 34, issue 12. p 2117, 2009.
Tavadyan LA, Galoian KA, Harutunyan LA, Tonikyan HG, Galoyan AA. Antioxidant and Electron Donating Function of Hypothalamic Polypeptides: Galarmin and Gx-NH(2).Neurochem Res. 35 (6):947-52, 2010 .
Felix, ER, Galoian, KA, Aarons, CE, Kearing, SA, Heiss, UE, Brown, MD: Utility of Computerized pain drawings .Pain Medicine, 11: 382-389, 2010.
Alexanyan M.K., Galoian K.A., Simonyan G.M., Stepanyan G.M., Simonyan R.M., Muradyan R.E., Alexanyan S.S., Simonyan M.A., Galoyan A.A. The increase of the NADPH depending superoxide-produsing and ferrihemoglobin-reducing activities of acidic nature isoform of cytochrome b558 from mouse sarcomas -37 tumor tissue cells under the influence of Proline-Rich Polypeptide (PRP-1) in vitro. Issues of Teoretical Klin.Med., 13(2): 54-57, 2010.
Simonyan G.M., Galoian K.A., Simonyan R.M., Simonyan M.A. and Galoyan A.A. Proline rich polypeptide increases the superoxide –producing and ferrihemoglobin reducing activities of cytochrome B558 isoforms from human lymphosarcoma tissue cells. Neurochemical research v36:739-745, 2011.
Galoian K.A, Temple H.T, Galoyan A.A. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by its inhibition of mTOR and cMyc in high grade metastatic chondrosarcoma Neurochem Res 36:812–818, 2011.
Galoian K.A Temple H.T, Galoyan A.A . Cytostatic effect of novel mTOR inhibitor, PRP-1 in MDA231 (ER-) breast carcinoma cell line. The cytokine inhibits mesenchymal tumors Tumor Biology Aug; 32(4):745-51, 2011.
Galoian, K.A Temple H.T Galoyan, A.A mTORC 1 inhibition in chondrosarcoma and ECM- cell adhesion independent drug resistance via PI3K-AKT feedback loop. Tumor Biology, 2012 33(3):885-90, 2012.
Durgaryan AA, Matevosyan MB, Seferyan TE, Sargsyan MA, Grigoryan S, Galoian KA and Galoyan AA. The Protective and Immunomodulatory Effects of Hypothalamic Proline Rich Polypeptide Galarmin against Methicillin-Resistant Staphylococcus aureus Infection in Mice. European Journal of Clinical Microbiology & Infectious Diseases. 31(9):2153-65, 2012.
K. Galoian, T. Guettouche, B.Issac ,L. Navarro and H.T. Temple. Lost miRNA surveillance of Notch, IGFR pathway- road to sarcomagenesis.Tumour Biology 35 (1) :483-492, 2014.
K. Galoian, T. Guettouche, B.Issac , A. Qureshi and H.T. Temple Regulation of onco and tumor suppressor miRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma Tumour Biol. 35(3):2335-41, 2014.
Karina Galoian, Amir Qureshi, Gina Wideroff, H.T. Temple. Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells. Molecular and Clinical Oncology 3: 171-178, 2015.
B. Issac, K. Galoian, T. Guettouche, Navarro, H.T. Temple. Genome-wide mRNA and miRNA expression data anlysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines. Genomics Data 2:320-324, 2015.
Galoian K.A,Qureshi A, Dippolito G,Schiller, P.C,Molinari M, Johnstone, A.L.Brothers,S.P Paz, A.C ,Temple H.T Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of praline rich polypeptide 1.lnternational Journal of Oncology, 47: 465-472, 2015.
Li L, Paz AC, Wilky BA, Johnson B, Galoian K, Rosenberg A, Hu G, Tinoco G, Bodamer, Trent JC. Bodamer O. Treatment with a small molecule IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in IDH1- mutant human chondro- sarcoma cells. PLOS One Sep 14; 10 (9):e0133813. doi: 10.1371, 2015.
Galoian K, Luo S, Qureshi A, Patel P, Price R, Morse A.S,Chailyan G , Abrahamyan, S, Temple, H.T. Proline rich polypeptide-1 and inflammatory pathway signaling in chondrosarcoma” Molecular and Clinical Oncology, 5:618-624, 2016.
Galoian K, Patel P. Epigenetic control of cancer by neuropeptides. Biomedical reports, (Spandidos publications) 6:3-7, 2017.
Patel P and Galoian K.. Molecular challenges of neuroendocrine tumors . Oncology letters , 15: 2715-2725, 2018.
Galoian K. Luo S, Patel P.Molecular Mechanisms of IL6 Downregulation In Chondrosarcoma- Mass Spectral Analyses Of Protein DNA Complexes. Biomedical Reports. 8: 91-98, 2018.
Galoian K, Abrahamyan S, Chailyan G, Qureshi A, Patel P, Metser G, Moran A, Sahakyan I, Tumasyan N, Lee A, Davtyan T, Chailyan S, Galoyan A.Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma. International Journal of Oncology (Spandidos publications), 52(1):139-154, 2018.
Aaron K. Hoyt, Alexandra Moran, Caroline Granger, Shannon Saigh, Anil Sedani,Jeffrey Brown and Karina A. Galoian. PRP-1 Eliminates ALDHhigh Cancer Stem Cell Population and Regulates Aberrant Wnt/β-catenin Pathway in Human JJ012 Chondrosarcoma Cells.Oncol Reports 42(1):103-114, 2019.
Luyuan Li, Xiaoyu Hu, Josiane E. Eid, Andrew E. Rosenberg, Breelyn A. Wilky, Yuguang Ban, Xiaodian Sun, Karina Galoian, Joanna DeSalvo, Jinbo Yue, Xi Steven Chen, Marzenna Blonska, Jonathan C. Trent Mutant IDH1 depletion downregulates integrins and impairs chondrosarcoma growth. Cancers 2020, 12(1), 141; https://doi.org/10.3390/cancers12010141 (registering DOI).
Abrahamyan S., Sahakyan I., Tumasyan N., Kocharyan N, Simonyan A, Aroutiounian R., Davtyan T., Chailyan S., Chailyan G. and Galoian K .Morpho-functional study of the hypothalamic proline rich polypeptide apoptotic activity against the mouse ehrlich ascites carcinoma. Oncology reports 2020, accepted.
Alexandra Moran, Aaron Hoyt, Anil Sedani, Caroline Granger; Marzenna Blonska, PhD; Liu Zhao-Jun, Sheila Conway, Juan Pretell, Jeffrey Brown and Karina Galoian,. Proline-Rich-Polypeptide (PRP-1) drastically decreases cancer stem cell (CSC) population targeting BAFF chromatin-remodeling-complexes in human chondrosarcoma JJ012-cells, Oncology reports accepted, 2020.